High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$1.5M
$1,526,485
Total Sells (Filtered)
$5.1M
$5,074,529
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| RAPP |
Rapport Therapeutics, Inc.
|
COO
Discretionary Sell
|
2026-03-05 | $58,265 | S | Form 4 |
|
RAPP
M
Rapport Therapeutics, Inc.
Bredt David
• Officer • Chief Scientific Officer
Other
2026-02-19
$10,800
|
||||||
| RAPP |
Rapport Therapeutics, Inc.
|
Officer • Chief Scientific Officer
Other
|
2026-02-19 | $10,800 | M | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2026-02-18 | $320,373x4 | S | Form 4 |
|
RAPP
S
Rapport Therapeutics, Inc.
Bredt David
• Officer • Chief Scientific Officer
10b5-1 Sell
2026-02-17
$246,655x3
|
||||||
| RAPP |
Rapport Therapeutics, Inc.
|
Officer • Chief Scientific Officer
10b5-1 Sell
|
2026-02-17 | $246,655x3 | S | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2026-01-20 | $285,071x2 | S | Form 4 |
|
RAPP
S
Rapport Therapeutics, Inc.
Bredt David
• Officer • Chief Scientific Officer
10b5-1 Sell
2026-01-15
$228,132x2
|
||||||
| RAPP |
Rapport Therapeutics, Inc.
|
Officer • Chief Scientific Officer
10b5-1 Sell
|
2026-01-15 | $228,132x2 | S | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-12-17 | $323,508x6 | S | Form 4 |
|
RAPP
S
Rapport Therapeutics, Inc.
Bredt David
• Officer • Chief Scientific Officer
10b5-1 Sell
2025-12-15
$255,130x2
|
||||||
| RAPP |
Rapport Therapeutics, Inc.
|
Officer • Chief Scientific Officer
10b5-1 Sell
|
2025-12-15 | $255,130x2 | S | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
COO
Equity Compensation
|
2025-11-26 | $9,000x2 | M | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
COO
10b5-1 Sell
|
2025-11-26 | $150,486 | S | Form 4 |
|
RAPP
S
Rapport Therapeutics, Inc.
Bredt David
• Officer • Chief Scientific Officer
10b5-1 Sell
2025-11-17
$214,091x2
|
||||||
| RAPP |
Rapport Therapeutics, Inc.
|
Officer • Chief Scientific Officer
10b5-1 Sell
|
2025-11-17 | $214,091x2 | S | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-11-17 | $275,047x4 | S | Form 4 |
|
RAPP
S
Rapport Therapeutics, Inc.
Bredt David
• Officer • Chief Scientific Officer
10b5-1 Sell
2025-10-15
$219,196x2
|
||||||
| RAPP |
Rapport Therapeutics, Inc.
|
Officer • Chief Scientific Officer
10b5-1 Sell
|
2025-10-15 | $219,196x2 | S | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-10-15 | $281,729x4 | S | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-09-17 | $2,011,197Largex4 | S | Form 4 |
|
RAPP
S
Rapport Therapeutics, Inc.
Bredt David
• Officer • Chief Scientific Officer
10b5-1 Sell
2025-09-15
$205,649x2
|
||||||
| RAPP |
Rapport Therapeutics, Inc.
|
Officer • Chief Scientific Officer
10b5-1 Sell
|
2025-09-15 | $205,649x2 | S | Form 4 |
| RAPP |
Rapport Therapeutics, Inc.
|
Director
Discretionary Buy
|
2025-09-12 | $499,374 | P | Form 4 |
|
RAPP
P
Rapport Therapeutics, Inc.
PAUL STEVEN M
• Director
Discretionary BuyΔOwn +47.3%
2025-09-12
$1,027,111Largex2
|
||||||
| RAPP |
Rapport Therapeutics, Inc.
|
Director
Discretionary BuyΔOwn +47.3%
|
2025-09-12 | $1,027,111Largex2 | P | Form 4 |